[1]
Yousif M. Al-dulaimy, W., Shaalan Sahab, K., Sabri Mohammed, E. and Kadhom, M. 2024. Role of blood hepcidin alteration as a biomarker in β-thalassemia patients’ diagnosis. Trends in Immunotherapy. 8, 1 (Apr. 2024). DOI:https://doi.org/10.24294/ti.v8.i1.4397.